Features

Therapeutic Focus CAR-T therapies: the future of cancer care, or an industry pipe dream?

CAR-T therapies: the future of cancer care, or an industry pipe dream?

While analysts predict a first-in-class appearance before the FDA by 2018, many obstacles have arisen.

Therapeutic Focus Top 25 oncology products in 2015

Top 25 oncology products in 2015

Despite the arrivals of new drugs, Genentech continues to be the market leader. Its drugs, Rituxan, Avastin, and Herceptin, are the category leaders, generating a total of $9.29 billion in sales.

Therapeutic Focus As immuno-oncology therapies evolve, so will the marketing

As immuno-oncology therapies evolve, so will the marketing

Interest in oncology is on the rise as the blockbuster drug era breathes its last, and this has altered marketing in cancer care.

Corporate Avanir marketing chief on selling first-in-class therapies

Avanir marketing chief on selling first-in-class therapies

Avanir's success with Nuedexta sparked the attention of several suitors. In 2014 the company reached a deal to be sold to Otsuka Pharmaceutical for around $3.5 billion

Features Read the complete July 2016 digital edition

Read the complete July 2016 digital edition

Read the 2016 Agency Issue in its entirety.

Features 100 quotes: What they reveal about the state of healthcare advertising

100 quotes: What they reveal about the state of healthcare advertising

Visions, challenges, and advice: Here are 100 quotes from 100 agency leaders, compiled from the MM&M Agency Issue.

Agency 3 questions for 5 of the agency world's leading executives

3 questions for 5 of the agency world's leading executives

Five executives from the industry's largest holding companies discuss their move away from the traditional network structure.

Agency How the healthcare agency solar system evolved this year

How the healthcare agency solar system evolved this year

A number of mergers and acquisitions among healthcare agencies in 2015 and 2016 changed the landscape.

Agency Revenues surge as agencies adapt to health-tech, payer trends

Revenues surge as agencies adapt to health-tech, payer trends

Healthcare agencies focus on freeing pharma brands from their collaboration cocoons to work with health tech companies, while squaring away access concerns.

Agency At Work With: Kantar Health's Tom Haskell

At Work With: Kantar Health's Tom Haskell

The co-founder of Mapquest.com talks about his move from online mapping to healthcare, and what he likes most meeting with clients.


The most recent MM&M Skill Sets Live event, "Personalizing the Healthcare Experience," surveyed a range of issues relating to some of the industry's hottest topics. This e-book conveys a wealth of information and opinion designed to help marketers demystify the challenges associated with the personalization of healthcare messaging. Click here to access.